As well as confirming the previously reported effects of ATO on tumor proliferation and apoptosis, our findings that ATO and its peptide-linked compound PhAs-LHP reduced pancreatic tumor growth by decreasing the expression of Skp2 in tumors have added to the mechanisms involved in the effects of ATO and PhAs-LHP. This evidence concerns the gene SKP2 and pancreatic neoplasm.